E2B per Month
| Month |
E2B |
| Feb 2025 | 512 |
|---|
| Mar 2025 | 116 |
|---|
| Apr 2025 | 648 |
|---|
| May 2025 | 197 |
|---|
| Jul 2024 | 1 |
|---|
| Aug 2024 | 1 |
|---|
| Sep 2024 | 1 |
|---|
| Oct 2024 | 1 |
|---|
| Dec 2024 | 2 |
|---|
E2B per Company
| Company |
E2B |
| Glaxosmithkline | 778 |
|---|
| HALEON | 142 |
|---|
| SAAVPROD | 110 |
|---|
| Novartis Pharma AG | 40 |
|---|
| Phillips | 33 |
|---|
| TAKEDA | 29 |
|---|
| VIIV HEALTHCARE LIMITED | 27 |
|---|
| NOVARTIS PHARMA | 27 |
|---|
| Boehringer Ingelheim | 26 |
|---|
| JNJFOC | 24 |
|---|
| Pfizer Inc | 23 |
|---|
| AstraZeneca | 21 |
|---|
| GlaxoSmithKline Export Ltd | 15 |
|---|
| Sanofi | 15 |
|---|
| 14 |
|---|
| BAYER | 13 |
|---|
| CIPLA | 12 |
|---|
| GLENMARK PHARMACEUTICALS | 12 |
|---|
| Pfizer | 10 |
|---|
| Norvatis Pharma | 9 |
|---|
| CIPLA LTD | 8 |
|---|
| BoehringerIngelheim | 7 |
|---|
| Macleods Pharmaceuticals Ltd | 6 |
|---|
| Surgipharm Limited | 6 |
|---|
| ROCHE | 5 |
|---|
| Gilead Pharmaceuticals Ltd | 5 |
|---|
| GlaxoSmithKlin | 5 |
|---|
| Ethypharm | 4 |
|---|
| UNIVERSAL CORPORATION LIMITED | 4 |
|---|
| JNJ | 4 |
|---|
| ABBVIE | 3 |
|---|
| AZPRODSE0 | 3 |
|---|
| Novartis | 3 |
|---|
| GILEAD | 2 |
|---|
| GSK | 2 |
|---|
| AZPROD | 2 |
|---|
| GlaxoSmithKlineds | 2 |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 2 |
|---|
| SAVPROD | 2 |
|---|
| TH-VIIV HEALTHCARE LIMITED | 2 |
|---|
| OPELLA | 2 |
|---|
| Surgipharm | 1 |
|---|
| KE-VIIV HEALTHCARE LIMITED | 1 |
|---|
| Novartis Kenya | 1 |
|---|
| Abbott GmbH | 1 |
|---|
| MACLEODS PHARMA | 1 |
|---|
| 95743049 | 1 |
|---|
| ACINO | 1 |
|---|
| E2B/2025/1332 | 1 |
|---|
| Merck Healthcare KGaA | 1 |
|---|
| Glenmark Pharmaceuticals Kenya Ltd | 1 |
|---|
| TORRENT | 1 |
|---|
| JNFOC | 1 |
|---|
| Phillips Therapeutics Ltd | 1 |
|---|
| Glenmark Pharmaceuticals Ltd | 1 |
|---|
| Bayer AG | 1 |
|---|
| PFIZERINC | 1 |
|---|
| NJFOC | 1 |
|---|
| Saarprod | 1 |
|---|
| GB-VIIV HEALTHCARE LIMITED | 1 |
|---|
| B|Braun Medical Kenya Ltd | 1 |
|---|
